Company profile
CorFlow Therapeutics company profile
CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complication rates in these patients.
Business identity
- Website
- https://corflow.com/
- Contact email
- [email protected]
- Phone number
- +41 41 544 55 55
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $1M-$10M
- Founded
- 2016-01-01, Year
Headquarters
- Headquarters
- Baar, Zug, Switzerland
- Country code
- CH
- Continent
- Europe